Stockscreener 앱 받기
6.57
1.70%
0.11
시간 외 거래:
6.57
전일 마감가:
$6.46
열려 있는:
$6.28
하루 거래량:
11,570
Relative Volume:
0.32
시가총액:
$3.57M
수익:
-
순이익/손실:
$-16.72M
주가수익비율:
-2.1546
EPS:
-3.0493
순현금흐름:
$-12.29M
1주 성능:
+2.18%
1개월 성능:
-17.34%
6개월 성능:
-38.92%
1년 성능:
-79.28%
1일 변동 폭
$6.28
$6.59
1주일 범위
$6.28
$6.8574
52주 변동 폭
$4.2042
$55.44
Autonomix Medical Inc Stock (AMIX) Company Profile
명칭
Autonomix Medical Inc
전화
832-277-7816
주소
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
6.57 | 3.57M | 0 | -16.72M | -12.29M | -3.0493 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Autonomix Medical Inc 주식(AMIX)의 최신 뉴스
Autonomix Medical, Inc. 8-K Filing: NASDAQ Compliance Update and Company Details (July 2026) - Minichart
Autonomix Medical Regains Nasdaq Compliance, Preserving Listing Status - TipRanks
Autonomix Medical regains Nasdaq compliance after 10-day $1.00 bid-price streak - TradingView
Autonomix Medical (NASDAQ: AMIX) restores Nasdaq minimum bid price compliance - Stock Titan
AMIXAutonomix Medical Inc Options - Finviz
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Company Advances R&DConsensus Forecast Report - dars.gov.et
Enterprise value to EBIT forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Price to book forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical Enacts 1-for-21 Reverse Stock Split - TipRanks
Autonomix Medical (AMIX) consolidates shares in 1-for-21 reverse stock split - Stock Titan
Autonomix Medical Inc (AMIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Autonomix Medical Announces Standalone Neural Sensing Platform with Evidence of Real-Time Renal Nerve Activity - marketscreener.com
Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change - GlobeNewswire
Autonomix sees real-time renal nerve activity changes in preclinical tests - Stock Titan
AMIX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Surprise Despite Stock DeclineAnalyst Earnings Estimate - dars.gov.et
Autonomix Medical announces 1-for-21 reverse stock split - MSN
AUTONOMIX ANNOUNCES REVERSE STOCK SPLIT - Moomoo
Autonomix Medical announces 1-for-21 reverse stock split By Investing.com - Investing.com Australia
Autonomix Announces Reverse Stock Split - GlobeNewswire
Autonomix Medical Inc (AMIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Autonomix Medical Inc (AMIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Autonomix Medical Inc (AMIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix’s shares will be cut 21-for-1 on June 24 - Stock Titan
Autonomix Medical Inc (AMIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Autonomix Medical Inc (AMIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Autonomix Medical Inc (AMIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
[10-K/A] Autonomix Medical, Inc. Amends Annual Report - Stock Titan
Autonomix Medical (AMIX) Shows Signs of Recovery After Recent DeclineIV Expansion Alert - dars.gov.et
AMIX Q1 2026 Earnings: Narrower-than-expected loss fails to lift sharesEarnings Growth Analysis - newsline.com
AMIX Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineHealthcare Earnings Report - newsline.com
Autonomix Medical, Inc. Financial Disclosures & SEC Filings - TradingView
AMIX Q1 2026 Earnings: Narrower-than-Expected Loss Driven by Disciplined Cost ManagementQuarterly Profit Report - newsline.com
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology - The Globe and Mail
Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why - MSN
Autonomix Medical (AMIX) Faces Continued Pressure Near $0.40 Support LevelDelta Hedging - newsline.com
Autonomix Medical executive discusses cancer pain treatment data By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. (AMIX) Latest Stock News & Headlines - Yahoo Finance
Autonomix Medical executive discusses cancer pain treatment data - Investing.com
Autonomix Medical Highlights Advances in Visceral Cancer Pain Treatment and Pancreatic Cancer Research in Investor Segment - Quiver Quantitative
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine - GlobeNewswire
Maxim Group Maintains Autonomix Medical(AMIX.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Autonomix Medical (AMIX) Declines 5.78% as Stock Tests Key Support at $0.37Break of Structure - dars.gov.et
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: EPS Surprise Delivers Narrower Loss, but Revenue Void Weighs on SharesRevenue Recognition Risk - newsline.com
Autonomix Medical, Inc.: Advancing Precision Neuro-Ablation for Pancreatic Cancer Pain with Innovative Sensing Technology and De Novo FDA Pathway 39 - Minichart
Autonomix Medical FY 2026: Revenue $0 Net loss $16.7M, EPS $(2.32) — 10-K Summary - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Autonomix Medical (NASDAQ: AMIX) outlines novel nerve device plans amid going concern risk - Stock Titan
Autonomix Medical, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Autonomix Medical (AMIX) Holds Steady Near Support as Traders Eye Resistance BreakoutLate Stage Breakouts - The Legal Advocate
Autonomix Medical Inc (AMIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
자본화:
|
볼륨(24시간):